started tirzepatide four weeks ago, .5mg, same sourcing situation a lot of people are working through post-prorx. came in expecting the food noise thing everyone describes and got basically nothing in the first two weeks. not a little less, just nothing noticeably different. week three is where it got harder to read. sleep shifted - went from maybe 5 hrs fragmented to closer to 6.5 most nights. and i genuinely can’t separate whether the slight appetite change i started noticing around day 22 is the tirz doing something, or whether better sleep just independently dialed down the background noise. that’s the confound i keep circling back to. what i actually logged: hunger scores (0-10 before meals), meal timing, sleep duration. week 1-2: hunger scores unchanged, 6-7 most days. week 3-4: drifting to 4-5, but sleep hours went up at the same time. still at .5. not convinced it’s not working - more like i can’t attribute what’s changing to what. anyone tracking both sleep and hunger side by side during titration? curious if the pattern matches.
the attribution problem you’re naming is real and it’s the part most “is it working yet” posts skip entirely. at 0.5mg the GLP-1 receptor occupancy isn’t doing much for appetite suppression anyway, that’s not really the therapeutic dose for the food noise effect, so a flat hunger score through weeks 1-2 is consistent with the PK curve more than it’s a signal of non-response. the more interesting question is what’s happening in week 3-4. sleep going from 5 fragmented to 6.5 is not a small delta. ghrelin runs higher under sleep restriction and leptin sensitivity drops, both of which independently move hunger scores in the direction you’re seeing. so on the n=1 level the confound is genuine and I don’t think you can resolve it from the data you have. what I’d want to see to start separating the two: hunger scores stratified by sleep tier. pull out the nights where you got under 6 hrs in the week 3-4 window and look at next-day hunger scores in isolation, then compare to the post 6.5-hr nights. if the appetite signal is still there on poor sleep nights, that’s tirz doing something. if hunger only drops on the well-slept days, the sleep mechanism is doing more of the work. it’s still not clean but it’s a step better than averaging across. the other thing worth naming: GI tolerance and PK steady state are not the same clock. by week 4 you’re approaching steady state on 0.5 but the dose itself is subtherapeutic for most people on the appetite axis. sitting longer at 0.5 to “wait and see” can be the wrong call depending on what you’re actually treating. worth raising with whoever’s prescribing. are you tracking anything alongside hunger and sleep, like cortisol-adjacent stuff or training load? those tend to be the next confound layer once the obvious two are accounted for.
the stratification idea is useful but it assumes the mechanism is uniform, and tirz isn’t sema - it’s dual GIP/GLP-1, and iirc the GIP arm doesn’t hit appetite suppression the same way or on the same timeline as the GLP-1 piece. most of the “food noise goes quiet” descriptions people share are probably describing the GLP-1 receptor contribution, which maps to what t.rousseau said abt subtherapeutic occupancy at 0.5. so even if you pull out the bad-sleep nights and a hunger score drop still shows up, you still can’t tell whether that’s early GLP-1 signal or whether the GIP component is doing something separately on a different clock. there isn’t a ton of clean published data on what GIP agonism specifically does to appetite in humans at low exposures, which kind of adds a second unlabeled variable on top of the sleep confound. not saying it changes the tracking approach, just that “tirz working” at week 3-4 might be two different mechanisms arriving at different times and the scores can’t separate them. probably worth naming that when you’re talking to whoever’s managing the titration.
one angle nobody’s pulled into this thread yet: the GIP receptor at low doses might actually be doing more on gut motility than appetite, which is its own confound for tracking. there’s some preclinical work showing GIP signaling modulates gastric emptying separately from the GLP-1 contribution, and at 0.5mg where GLP-1 occupancy is sub therapeutic, GIP-mediated motility shifts could be the thing actually moving meal-to-meal hunger scores without anyone perceiving a “food noise” change. translation: if your stomach is emptying ~15-20% slower, the hunger 4-5 you’re logging at week 3-4 might be a delayed-fullness artifact, not central appetite suppression at all. that’s a separate mechanism on a separate clock from the GLP-1 piece PulseSignal already named, and from the sleep confound. what would actually help disambiguate: log time-from-meal-to-hunger-return alongside the pre-meal hunger score. if the score drop is GIP-mediated gastric slowing, the interval between meals should be stretching even when the absolute hunger numbers look similar. if it’s GLP-1 central signaling, you’d expect the score to drop without the inter-meal interval shifting as much. it’s not a clean separation but it’s a second axis the 0-10 score alone can’t capture. other thing worth naming: postprandial glucose response. i don’t know if you have CGM access but if you do, the GIP contribution to insulinotropic response shows up earlier in tirz titration than the appetite piece does for a lot of people, and that’s a measurable signal that doesn’t depend on subjective scoring. for non-T2D users this is less actionable but the pattern is still there in published data. iirc the postprandial AUC shifts in the first few weeks even at low doses where the subjective appetite stuff is mostly absent. your endo or whoever is managing this will have a better read on whether 0.5 is the right place to sit given what you’re logging. but the gastric emptying angle is worth adding to the troubleshoot list.
the .5 starter dose is sub-therapeutic by design, it’s a tolerability ramp not an effect dose, so “is it working at week 4 on .5” is mostly the wrong question and the sleep confound is doing you a favor by making that clearer. if you want to actually isolate it, the cleaner read is post-titration to 2.5 or 5 with sleep already stabilized, otherwise you’re trying to pull signal off a dose that wasn’t built to produce one.
edit: realized I said that wrong
ghrelin runs meaningfully higher on restricted sleep, and leptin suppression follows – 5 hours versus 6.5 is enough of a gap to independently shift baseline hunger signaling. so the score drop you logged in weeks 3-4 has at least two plausible drivers that are mechanistically tangled, not just correlated. clean attribution really needs a window where sleep is stable first, which you don’t have here.
sleep going from 5 fragmented to 6.5 is not a small confound, that alone can drop ghrelin and bump leptin enough to move hunger scores a full point or two, and the timing lines up with what you’re seeing. the disambiguation i’d want isn’t more weeks at .5, it’s whether the hunger drop holds on a night you sleep badly. if you get a 4hr night in week 5 and hunger scores stay at 4-5, that’s tirz doing work independent of sleep. if they bounce back to 6-7, sleep was carrying most of it. fwiw “drifting to 4-5” on a 0-10 is also right in the noise band for self-rated hunger, the test-retest on those scales is messier than people log them as. one more variable worth adding: time-of-day for the score, because the sleep effect on hunger is heaviest in the morning window.
the case for “i can’t separate the two” is fair, you logged it honestly and the timing genuinely is confounded. but i’d push back on treating it as a 50/50 attribution problem, because the magnitudes aren’t equal here. sleep going from 5 fragmented to 6.5 consolidated is a much bigger metabolic input than 4 weeks at .5mg tirz, which is a starter dose specifically chosen because it’s mostly a tolerance check, not a therapeutic appetite dose for most people. ghrelin response to sleep extension is well-documented in the sleep-restriction literature and the effect size is not small, a 1.5 hour gain in consolidated sleep can drop morning hunger scores 1-2 points on its own. the cleaner test, if you wanted one, is to watch what happens at the next titration step while sleep stays stable. if hunger drops again on a flat sleep baseline that’s a different signal than the one you’re reading now. right now i’d lean sleep is doing more of the work than the tirz at this dose, but worth bringing to your prescriber.
sleep independently dialing down hunger scores is real and underrated - orexin and ghrelin have a documented relationship, so the 1.5hr sleep gain you’re logging is not a neutral variable. the confound you’re naming (“can’t attribute what’s changing to what”) is genuinely hard to untangle at .5mg bc the dose is sub-therapeutic for a lot of people and the effect size at that floor is small enough to get buried. the approach i’d try: look at hunger scores specifically on the mornings after your worst sleep nights from weeks 3-4. if tirz is doing something independent of sleep, you should still see suppression there. if scores track sleep quality consistently, that tells you something about mechanism.
your sleep-to-appetite link isn’t actually confounding - it’s real physiology. an extra 1.5 hrs of actual sleep genuinely lowers ghrelin independent of the drug, so your suspicion is right. you’re just trying to separate baseline human biology from what the tirz is actually doing. have you tracked whether the sleep improvement held into week 4, or did it already start fragmenting back down? knowing that specific pattern would actually help you read week 5 more clearly.
The confound you’re naming is one I sat with on my own logs for months. Five hours of fragmented sleep can push ghrelin measurably higher in some populations, so 1.5 extra hours arriving at the exact same week your hunger scores drift from 6-7 to 4-5 makes clean attribution genuinely difficult. What I’d note though: day 22 also roughly aligns with when tirz would be approaching steady state at weekly dosing, which means both mechanisms could be running in parallel rather than one masking the other. It may not be either/or. imo If you can track your hunger scores specifically around trough, around day 5-6 after injection when drug levels are lowest, you’d have something to compare against the first 48hrs post-dose. That window is where the pharmacological contribution gets a bit more legible. The sleep signal won’t disappear, but the spread between trough and peak hunger scores starts to tell you something the weekly average can’t.